Cargando…
ME2 Promotes Hepatocellular Carcinoma Cell Migration through Pyruvate
Cancer metastasis is still a major challenge in clinical cancer treatment. The migration and invasion of cancer cells into surrounding tissues and blood vessels is the primary step in cancer metastasis. However, the underlying mechanism of regulating cell migration and invasion are not fully underst...
Autores principales: | Yang, Yanting, Zhang, Zhenxi, Li, Wei, Li, Li, Zhou, Ying, Du, Wenjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145348/ https://www.ncbi.nlm.nih.gov/pubmed/37110198 http://dx.doi.org/10.3390/metabo13040540 |
Ejemplares similares
-
Function of mitochondrial pyruvate carriers in hepatocellular carcinoma patients
por: Ma, Xiangming, et al.
Publicado: (2018) -
Malic enzyme 2 as a therapeutic target for cancer: comments on ‘Malic enzyme 2 maintains protein stability of mutant p53 through 2-hydroxyglutarate’
por: Zhang, Zhenxi, et al.
Publicado: (2022) -
NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
por: Zhang, Yi, et al.
Publicado: (2018) -
SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma
por: Tai, Wei-Tien, et al.
Publicado: (2016) -
Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1
por: Li, Aiyun, et al.
Publicado: (2018)